Clinical Trial

A Phase 1 Study of S-1117

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This is the first-in-human study of S-1117 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-10.
Status change: Not Yet Recruiting → Recruiting 2025-03-09
Trial Details
NCT Number NCT06828393
Lead Sponsor Seismic Therapeutic AU Pty Ltd
Collaborators: Avance Clinical Pty Ltd.
Conditions Healthy Volunteer
Enrollment 96 participants
Start Date 2025-03
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-03-12